| 000 | 01176 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515163450.0 | ||
| 264 | 0 | _c20100107 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1879-0046 | ||
| 024 | 7 |
_a10.1016/j.drugalcdep.2009.02.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeiderman, Deborah B | |
| 245 | 0 | 0 |
_aRisk management of drug products and the U.S. Food and Drug Administration: evolution and context. _h[electronic resource] |
| 260 |
_bDrug and alcohol dependence _cDec 2009 |
||
| 300 |
_aS9-S13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCentral Nervous System Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRisk Management _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xprevention & control |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
| 773 | 0 |
_tDrug and alcohol dependence _gvol. 105 Suppl 1 _gp. S9-S13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drugalcdep.2009.02.007 _zAvailable from publisher's website |
| 999 |
_c18744727 _d18744727 |
||